메뉴 건너뛰기




Volumn 37, Issue 1, 2016, Pages 11-20

Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review)

Author keywords

3GT; Anti Gal antibody; Clinical exploitation; Mammalian evolution; gal epitope; 1

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ALPHA GALACTOSIDASE; ALPHA GALACTOSIDASE NANOPARTICLE; ANTIBODY; EPITOPE; GALACTOSIDASE ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; NANOPARTICLE; TUMOR VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; ALPHA-GALACTOSYL EPITOPE; GALACTOSYLTRANSFERASE; N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE; TRISACCHARIDE;

EID: 84948756587     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2397     Document Type: Review
Times cited : (71)

References (84)
  • 1
    • 0037008717 scopus 로고    scopus 로고
    • Structural basis of ordered binding of donor and acceptor substrates to the retaining glycosyltransferase, alpha-1,3-galactosyltransferase
    • Boix E, Zhang Y, Swaminathan GJ, Brew K and Acharya KR: Structural basis of ordered binding of donor and acceptor substrates to the retaining glycosyltransferase, alpha-1,3-galactosyltransferase. J Biol Chem 277: 28310-28318, 2002.
    • (2002) J Biol Chem , vol.277 , pp. 28310-28318
    • Boix, E.1    Zhang, Y.2    Swaminathan, G.J.3    Brew, K.4    Acharya, K.R.5
  • 3
    • 22944476837 scopus 로고    scopus 로고
    • The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy
    • Galili U: The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 83: 674-686, 2005.
    • (2005) Immunol Cell Biol , vol.83 , pp. 674-686
    • Galili, U.1
  • 4
    • 0022350361 scopus 로고
    • Biosynthesis of terminal Gal alpha 1→3Gal beta 1→4GlcNAc-R oligosaccharide sequences on glycoconjugates. Purification and acceptor specificity of a UDP-Gal:N-acetyllactosaminide alpha 1→3-galactosyltransferase from calf thymus
    • Blanken WM and Van den Eijnden DH: Biosynthesis of terminal Gal alpha 1→3Gal beta 1→4GlcNAc-R oligosaccharide sequences on glycoconjugates. Purification and acceptor specificity of a UDP-Gal:N-acetyllactosaminide alpha 1→3-galactosyltransferase from calf thymus. J Biol Chem 260: 12927-12934, 1985.
    • (1985) J Biol Chem , vol.260 , pp. 12927-12934
    • Blanken, W.M.1    Van Den Eijnden, D.H.2
  • 5
    • 0038394491 scopus 로고    scopus 로고
    • Characterization of the rat alpha (1, 3)galactosyltransferase: Evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways
    • Taylor SG, McKenzie IF and Sandrin MS: Characterization of the rat alpha(1,3)galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galalpha(1,3)Gal by two separate glycosylation pathways. Glycobiology 13: 327-337, 2003.
    • (2003) Glycobiology , vol.13 , pp. 327-337
    • Taylor, S.G.1    McKenzie, I.F.2    Sandrin, M.S.3
  • 6
    • 0025895390 scopus 로고
    • Characterization of an alpha 1→3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene
    • Joziasse DH, Shaper JH, Jabs EW and Shaper NL: Characterization of an alpha 1→3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J Biol Chem 266: 6991-6998, 1991.
    • (1991) J Biol Chem , vol.266 , pp. 6991-6998
    • Joziasse, D.H.1    Shaper, J.H.2    Jabs, E.W.3    Shaper, N.L.4
  • 12
    • 0027295654 scopus 로고
    • Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody
    • Galili U: Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol 15: 155-171, 1993.
    • (1993) Springer Semin Immunopathol , vol.15 , pp. 155-171
    • Galili, U.1
  • 13
    • 0025264624 scopus 로고
    • Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal (1, 4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA
    • Larsen RDR-MC, Rivera-Marrero CA, Ernst LK, Cummings RD and Lowe JB: Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA. J Biol Chem 265: 7055-7061, 1990.
    • (1990) J Biol Chem , vol.265 , pp. 7055-7061
    • Rdr-Mc, L.1    Rivera-Marrero, C.A.2    Ernst, L.K.3    Cummings, R.D.4    Lowe, J.B.5
  • 14
    • 84880636408 scopus 로고    scopus 로고
    • Possible role of a cell surface carbohydrate in evolution of resistance to viral infections in old world primates
    • Rodriguez IA and Welsh RM: Possible role of a cell surface carbohydrate in evolution of resistance to viral infections in old world primates. J Virol 87: 8317-8326, 2013.
    • (2013) J Virol , vol.87 , pp. 8317-8326
    • Rodriguez, I.A.1    Welsh, R.M.2
  • 16
    • 0029097560 scopus 로고
    • Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations
    • Wang L, Radic MZ and Galili U: Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. J Immunol 155: 1276-1285, 1995.
    • (1995) J Immunol , vol.155 , pp. 1276-1285
    • Wang, L.1    Radic, M.Z.2    Galili, U.3
  • 17
    • 84872610574 scopus 로고    scopus 로고
    • Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal)
    • Commins SP and Platts-Mills TA: Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal). Curr Allergy Asthma Rep 13: 72-77, 2013.
    • (2013) Curr Allergy Asthma Rep , vol.13 , pp. 72-77
    • Commins, S.P.1    Platts-Mills, T.A.2
  • 18
    • 0032571848 scopus 로고    scopus 로고
    • A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody
    • Galili U, LaTemple DC and Radic MZ: A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody. Transplantation 65: 1129-1132, 1998.
    • (1998) Transplantation , vol.65 , pp. 1129-1132
    • Galili, U.1    LaTemple, D.C.2    Radic, M.Z.3
  • 19
    • 0031688001 scopus 로고    scopus 로고
    • Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase
    • LaTemple DC and Galili U: Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase. Xenotransplantation 5: 191-196, 1998.
    • (1998) Xenotransplantation , vol.5 , pp. 191-196
    • LaTemple, D.C.1    Galili, U.2
  • 20
    • 75349103556 scopus 로고    scopus 로고
    • Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A
    • Park S, Kim WH, Choi SY and Kim YJ: Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A. J Korean Med Sci 24: 1126-1131, 2009.
    • (2009) J Korean Med Sci , vol.24 , pp. 1126-1131
    • Park, S.1    Kim, W.H.2    Choi, S.Y.3    Kim, Y.J.4
  • 21
    • 34548157925 scopus 로고    scopus 로고
    • Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells
    • Abdel-Motal UM, Guay HM, Wigglesworth K, Welsh RM and Galili U: Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells. J Virol 81: 9131-9141, 2007.
    • (2007) J Virol , vol.81 , pp. 9131-9141
    • Abdel-Motal, U.M.1    Guay, H.M.2    Wigglesworth, K.3    Welsh, R.M.4    Galili, U.5
  • 23
    • 0029942885 scopus 로고    scopus 로고
    • Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose
    • LaTemple DC, Henion TR, Anaraki F and Galili U: Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose. Cancer Res 56: 3069-3074, 1996.
    • (1996) Cancer Res , vol.56 , pp. 3069-3074
    • LaTemple, D.C.1    Henion, T.R.2    Anaraki, F.3    Galili, U.4
  • 24
    • 0033517356 scopus 로고    scopus 로고
    • Cutaneous wound healing
    • Singer AJ and Clark RA: Cutaneous wound healing. N Engl J Med 341: 738-746, 1999.
    • (1999) N Engl J Med , vol.341 , pp. 738-746
    • Singer, A.J.1    Clark, R.A.2
  • 25
    • 0002734078 scopus 로고    scopus 로고
    • Transgenic approaches for the reduction of Galalpha (1, 3)Gal for xenotransplantation
    • Sandrin MS, Osman N and McKenzie IF: Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation. Front Biosci 2: e1-11, 1997.
    • (1997) Front Biosci , vol.2 , pp. e1-11
    • Sandrin, M.S.1    Osman, N.2    McKenzie, I.F.3
  • 26
    • 0030472766 scopus 로고    scopus 로고
    • Switching amino-terminal cytoplasmic domains of alpha (1, 2)fucosyltransferase and alpha(1,3)galactosyltransferase alters the expression of H substance and Galalpha(1,3)Gal
    • Osman N, McKenzie IF, Mouhtouris E and Sandrin MS: Switching amino-terminal cytoplasmic domains of alpha(1,2)fucosyltransferase and alpha(1,3)galactosyltransferase alters the expression of H substance and Galalpha(1,3)Gal. J Biol Chem 271: 33105-33109, 1996.
    • (1996) J Biol Chem , vol.271 , pp. 33105-33109
    • Osman, N.1    McKenzie, I.F.2    Mouhtouris, E.3    Sandrin, M.S.4
  • 27
    • 0035376204 scopus 로고    scopus 로고
    • Adenovirus-mediated expression of pig alpha(1, 3) galactosyltransferase reconstructs Gal alpha(1, 3) gal epitope on the surface of human tumor cells
    • Xing L, Xia GH, Fei J, Huang F and Guo LH: Adenovirus-mediated expression of pig alpha(1,3) galactosyltransferase reconstructs Gal alpha(1, 3) gal epitope on the surface of human tumor cells. Cell Res 11: 116-124, 2001.
    • (2001) Cell Res , vol.11 , pp. 116-124
    • Xing, L.1    Xia, G.H.2    Fei, J.3    Huang, F.4    Guo, L.H.5
  • 28
    • 84860244022 scopus 로고    scopus 로고
    • Cloning of splicing variants of alpha1,3-galactosyltransferase cDNA of Chinese Banna Minipig inbred line and its expression in human cells
    • In Chinese
    • Liu M, Zhu SM, Zheng H, Wang Y, Wang Z, Yang YJ, Wu YX, Zeng YZ and Wang YP: Cloning of splicing variants of alpha1,3-galactosyltransferase cDNA of Chinese Banna Minipig inbred line and its expression in human cells. Sichuan Da Xue Xue Bao Yi Xue Ban 43: 145-150, 2012 (In Chinese).
    • (2012) Sichuan da Xue Xue Bao Yi Xue Ban , vol.43 , pp. 145-150
    • Liu, M.1    Zhu, S.M.2    Zheng, H.3    Wang, Y.4    Wang, Z.5    Yang, Y.J.6    Wu, Y.X.7    Zeng, Y.Z.8    Wang, Y.P.9
  • 29
    • 0024310039 scopus 로고
    • Bovine alpha 1→3-galactosyltransferase: Isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA
    • Joziasse DH, Shaper JH, Van den Eijnden DH, Van Tunen AJ and Shaper NL: Bovine alpha 1→3-galactosyltransferase: Isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA. J Biol Chem 264: 14290-14297, 1989.
    • (1989) J Biol Chem , vol.264 , pp. 14290-14297
    • Joziasse, D.H.1    Shaper, J.H.2    Van Den Eijnden, D.H.3    Van Tunen, A.J.4    Shaper, N.L.5
  • 30
    • 0036966210 scopus 로고    scopus 로고
    • A complete alpha1,3-galactosyltransferase gene is present in the human genome and partially transcribed
    • Lantéri M, Giordanengo V, Vidal F, Gaudray P and Lefebvre JC: A complete alpha1,3-galactosyltransferase gene is present in the human genome and partially transcribed. Glycobiology 12: 785-792, 2002.
    • (2002) Glycobiology , vol.12 , pp. 785-792
    • Lantéri, M.1    Giordanengo, V.2    Vidal, F.3    Gaudray, P.4    Lefebvre, J.C.5
  • 31
    • 0025773203 scopus 로고
    • Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys
    • Galili U and Swanson K: Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 88: 7401-7404, 1991.
    • (1991) Proc Natl Acad Sci USA , vol.88 , pp. 7401-7404
    • Galili, U.1    Swanson, K.2
  • 32
    • 0035104486 scopus 로고    scopus 로고
    • Human xenoreactivity is reduced in mice bearing porcine antisense alpha(1, 3) galactosyltransferase cDNA
    • Ma YH, Zhou XG, Hu JH, Fei J, Xia GH and Guo LH: Human xenoreactivity is reduced in mice bearing porcine antisense alpha(1,3) galactosyltransferase cDNA. Acta Pharmacol Sin 22: 231-238, 2001.
    • (2001) Acta Pharmacol Sin , vol.22 , pp. 231-238
    • Ma, Y.H.1    Zhou, X.G.2    Hu, J.H.3    Fei, J.4    Xia, G.H.5    Guo, L.H.6
  • 33
    • 0001207979 scopus 로고
    • Suppression of a-galactosyl epitopes synthesis and production of the natural anti-Gal antibody: A major evolutionary event in ancestral Old World primates
    • Galili U and Andrews P: Suppression of a-galactosyl epitopes synthesis and production of the natural anti-Gal antibody: A major evolutionary event in ancestral Old World primates. J Hum Evol 29: 433-442, 1995.
    • (1995) J Hum Evol , vol.29 , pp. 433-442
    • Galili, U.1    Andrews, P.2
  • 36
    • 0027517325 scopus 로고
    • Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes
    • Sandrin MS, Vaughan HA, Dabkowski PL and McKenzie IF: Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci USA 90: 11391-11395, 1993.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 11391-11395
    • Sandrin, M.S.1    Vaughan, H.A.2    Dabkowski, P.L.3    McKenzie, I.F.4
  • 37
    • 0021678856 scopus 로고
    • A unique natural human IgG antibody with anti-A-Galactosyl specificity
    • Galili U, Rachmilewitz EA, Peleg A and Flechner I: A unique natural human IgG antibody with anti-a-galactosyl specificity. J Exp Med 160: 1519-1581, 1984.
    • (1984) J Exp Med , vol.160 , pp. 1519-1581
    • Galili, U.1    Rachmilewitz, E.A.2    Peleg, A.3    Flechner, I.4
  • 38
    • 84883221480 scopus 로고    scopus 로고
    • Anti-Gal: An abundant human natural antibody of multiple pathogeneses and clinical benefits
    • Galili U: Anti-Gal: An abundant human natural antibody of multiple pathogeneses and clinical benefits. Immunology 140: 1-11, 2013.
    • (2013) Immunology , vol.140 , pp. 1-11
    • Galili, U.1
  • 39
    • 84920556346 scopus 로고    scopus 로고
    • Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys
    • Galili U: Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys. J Mol Evol 80: 1-9, 2015.
    • (2015) J Mol Evol , vol.80 , pp. 1-9
    • Galili, U.1
  • 40
    • 0035104486 scopus 로고    scopus 로고
    • Human xenoreactivity is reduced in mice bearing porcine antisense alpha(1, 3) galactosyltransferase cDNA
    • Ma YH1, Zhou XG, Hu JH, Fei J, Xia GH, Guo LH: Human xenoreactivity is reduced in mice bearing porcine antisense alpha(1,3) galactosyltransferase cDNA. Acta Pharmacol Sin 22: 231-238, 2001.
    • (2001) Acta Pharmacol Sin , vol.22 , pp. 231-238
    • Yh, M.1    Zhou, X.G.2    Hu, J.H.3    Fei, J.4    Xia, G.H.5    Guo, L.H.6
  • 41
    • 0023217305 scopus 로고
    • Modulation of the immunological response to hepatitis B virus by antibodies
    • Celis E, Abraham KG and Miller RW: Modulation of the immunological response to hepatitis B virus by antibodies. Hepatology 7: 563-568, 1987.
    • (1987) Hepatology , vol.7 , pp. 563-568
    • Celis, E.1    Abraham, K.G.2    Miller, R.W.3
  • 42
    • 79951516280 scopus 로고    scopus 로고
    • Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation
    • Byrne GW, Stalboerger PG, Du Z, Davis TR and McGregor CG: Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 91: 287-292, 2011.
    • (2011) Transplantation , vol.91 , pp. 287-292
    • Byrne, G.W.1    Stalboerger, P.G.2    Du, Z.3    Davis, T.R.4    McGregor, C.G.5
  • 43
    • 0027508081 scopus 로고
    • Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: A major obstacle for xenotransplantation in humans
    • Galili U: Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol Today 14: 480-482, 1993.
    • (1993) Immunol Today , vol.14 , pp. 480-482
    • Galili, U.1
  • 44
    • 33645764958 scopus 로고    scopus 로고
    • Xenotransplantation: A bioethical evaluation
    • Anderson M: Xenotransplantation: A bioethical evaluation. J Med Ethics 32: 205-208, 2006.
    • (2006) J Med Ethics , vol.32 , pp. 205-208
    • Anderson, M.1
  • 45
    • 84871699106 scopus 로고    scopus 로고
    • Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: Feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts
    • Lee C, Ahn H, Kim SH, Choi SY and Kim YJ: Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts. Eur J Cardiothorac Surg 42: 164-172, 2012.
    • (2012) Eur J Cardiothorac Surg , vol.42 , pp. 164-172
    • Lee, C.1    Ahn, H.2    Kim, S.H.3    Choi, S.Y.4    Kim, Y.J.5
  • 46
    • 47249100755 scopus 로고    scopus 로고
    • Structural analysis of alpha-Gal and new non-Gal carbohydrate epitopes from specific pathogen-free miniature pig kidney
    • Kim YG, Gil GC, Harvey DJ and Kim BG: Structural analysis of alpha-Gal and new non-Gal carbohydrate epitopes from specific pathogen-free miniature pig kidney. Proteomics 8: 2596-2610, 2008.
    • (2008) Proteomics , vol.8 , pp. 2596-2610
    • Kim, Y.G.1    Gil, G.C.2    Harvey, D.J.3    Kim, B.G.4
  • 47
    • 84880528243 scopus 로고    scopus 로고
    • Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults
    • Park CS, Oh SS, Kim YE, Choi SY, Lim HG, Ahn H and Kim YJ: Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults. J Heart Valve Dis 22: 222-229, 2013.
    • (2013) J Heart Valve Dis , vol.22 , pp. 222-229
    • Park, C.S.1    Oh, S.S.2    Kim, Y.E.3    Choi, S.Y.4    Lim, H.G.5    Ahn, H.6    Kim, Y.J.7
  • 48
    • 84920762219 scopus 로고    scopus 로고
    • Biomechanical properties of hybrid heart valve prosthesis utilizing the pigs that do not express the galactose-α-1,3-galactose (α-Gal) antigen derived tissue and tissue engineering technique
    • Wilczek P, Lesiak A, Niemiec-Cyganek A, Kubin B, Slomski R, Nozynski J, Wilczek G, Mzyk A and Gramatyka M: Biomechanical properties of hybrid heart valve prosthesis utilizing the pigs that do not express the galactose-α-1,3-galactose (α-Gal) antigen derived tissue and tissue engineering technique. J Mater Sci Mater Med 26: 5329, 2015.
    • (2015) J Mater Sci Mater Med , vol.26 , pp. 5329
    • Wilczek, P.1    Lesiak, A.2    Niemiec-Cyganek, A.3    Kubin, B.4    Slomski, R.5    Nozynski, J.6    Wilczek, G.7    Mzyk, A.8    Gramatyka, M.9
  • 49
    • 84866037252 scopus 로고    scopus 로고
    • Elimination of alpha-gal xenoreactive epitope: Alpha-galactosidase treatment of porcine heart valves
    • Choi SY, Jeong HJ, Lim HG, Park SS, Kim SH and Kim YJ: Elimination of alpha-gal xenoreactive epitope: Alpha-galactosidase treatment of porcine heart valves. J Heart Valve Dis 21: 387-397, 2012.
    • (2012) J Heart Valve Dis , vol.21 , pp. 387-397
    • Choi, S.Y.1    Jeong, H.J.2    Lim, H.G.3    Park, S.S.4    Kim, S.H.5    Kim, Y.J.6
  • 51
    • 0029039406 scopus 로고
    • Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection
    • Collins BH, Cotterell AH, McCurry KR, Alvarado CG, Magee JC, Parker W and Platt JL: Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. J Immunol 154: 5500-5510, 1995.
    • (1995) J Immunol , vol.154 , pp. 5500-5510
    • Collins, B.H.1    Cotterell, A.H.2    McCurry, K.R.3    Alvarado, C.G.4    Magee, J.C.5    Parker, W.6    Platt, J.L.7
  • 52
    • 84864717332 scopus 로고    scopus 로고
    • Porcine bioprosthetic heart valves: The next generation
    • Manji RA, Menkis AH, Ekser B and Cooper DK: Porcine bioprosthetic heart valves: The next generation. Am Heart J 164: 177-185, 2012.
    • (2012) Am Heart J , vol.164 , pp. 177-185
    • Manji, R.A.1    Menkis, A.H.2    Ekser, B.3    Cooper, D.K.4
  • 53
    • 79955536634 scopus 로고    scopus 로고
    • Comparison of Gal and non-Gal-mediated cardiac xenograft rejection
    • Tazelaar HD, Byrne GW and McGregor CG: Comparison of Gal and non-Gal-mediated cardiac xenograft rejection. Transplantation 91: 968-975, 2011.
    • (2011) Transplantation , vol.91 , pp. 968-975
    • Tazelaar, H.D.1    Byrne, G.W.2    McGregor, C.G.3
  • 54
    • 84887116491 scopus 로고    scopus 로고
    • In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse
    • Lim HG, Choi SY, Yoon EJ, Kim SH and Kim YJ: In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse. Tissue Eng Part A 19: 2339-2348, 2013.
    • (2013) Tissue Eng Part A , vol.19 , pp. 2339-2348
    • Lim, H.G.1    Choi, S.Y.2    Yoon, E.J.3    Kim, S.H.4    Kim, Y.J.5
  • 55
    • 78650281042 scopus 로고    scopus 로고
    • Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves
    • McGregor CG, Carpentier A, Lila N, Logan JS and Byrne GW: Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves. J Thorac Cardiovasc Surg 141: 269-275, 2011.
    • (2011) J Thorac Cardiovasc Surg , vol.141 , pp. 269-275
    • McGregor, C.G.1    Carpentier, A.2    Lila, N.3    Logan, J.S.4    Byrne, G.W.5
  • 57
    • 84872529498 scopus 로고    scopus 로고
    • Changes of the structural and biomechanical properties of the bovine pericardium after the removal of α-Gal epitopes by decellularization and α-galactosidase treatment
    • Nam J, Choi SY, Sung SC, Lim HG, Park SS, Kim SH and Kim YJ: Changes of the structural and biomechanical properties of the bovine pericardium after the removal of α-Gal epitopes by decellularization and α-galactosidase treatment. Korean J Thorac Cardiovasc Surg 45: 380-389, 2012.
    • (2012) Korean J Thorac Cardiovasc Surg , vol.45 , pp. 380-389
    • Nam, J.1    Choi, S.Y.2    Sung, S.C.3    Lim, H.G.4    Park, S.S.5    Kim, S.H.6    Kim, Y.J.7
  • 58
    • 24944519280 scopus 로고    scopus 로고
    • Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves
    • Kasimir MT, Rieder E, Seebacher G, Wolner E, Weigel G and Simon P: Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng 11: 1274-1280, 2005.
    • (2005) Tissue Eng , vol.11 , pp. 1274-1280
    • Kasimir, M.T.1    Rieder, E.2    Seebacher, G.3    Wolner, E.4    Weigel, G.5    Simon, P.6
  • 60
    • 32044445822 scopus 로고    scopus 로고
    • The molecular basis for galalpha (1, 3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene
    • Milland J, Christiansen D, Lazarus BD, Taylor SG, Xing PX and Sandrin MS: The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene. J Immunol 176: 2448-2454, 2006.
    • (2006) J Immunol , vol.176 , pp. 2448-2454
    • Milland, J.1    Christiansen, D.2    Lazarus, B.D.3    Taylor, S.G.4    Xing, P.X.5    Sandrin, M.S.6
  • 62
    • 33846620083 scopus 로고    scopus 로고
    • Replacement of human anterior cruciate ligaments with pig ligaments: A model for anti-non-gal antibody response in long-term xenotransplantation
    • Stone KR, Abdel-Motal UM, Walgenbach AW, Turek TJ and Galili U: Replacement of human anterior cruciate ligaments with pig ligaments: A model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation 83: 211-219, 2007.
    • (2007) Transplantation , vol.83 , pp. 211-219
    • Stone, K.R.1    Abdel-Motal, U.M.2    Walgenbach, A.W.3    Turek, T.J.4    Galili, U.5
  • 63
    • 84948751760 scopus 로고    scopus 로고
    • Comparative N-linked glycan analysis of wild-type and α1,3-galactosyltransferase gene knock-out pig fibroblasts using mass spectrometry approaches
    • Park HM, Kim YW, Kim KJ, Kim YJ, Yang YH, Jin JM, Kim YH, Kim BG, Shim H and Kim YG: Comparative N-linked glycan analysis of wild-type and α1,3-galactosyltransferase gene knock-out pig fibroblasts using mass spectrometry approaches. Mol Cells 38: 65-74, 2015.
    • (2015) Mol Cells , vol.38 , pp. 65-74
    • Park, H.M.1    Kim, Y.W.2    Kim, K.J.3    Kim, Y.J.4    Yang, Y.H.5    Jin, J.M.6    Kim, Y.H.7    Kim, B.G.8    Shim, H.9    Kim, Y.G.10
  • 64
    • 38749117878 scopus 로고    scopus 로고
    • The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: A carbohydrate of unique evolution and clinical relevance
    • Macher BA and Galili U: The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: A carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 1780: 75-88, 2008.
    • (2008) Biochim Biophys Acta , vol.1780 , pp. 75-88
    • Macher, B.A.1    Galili, U.2
  • 65
    • 0036232834 scopus 로고    scopus 로고
    • Expression of alpha-gal epitopes on HeLa cells transduced with adenovirus containing alpha1,3galactosyltransferase cDNA
    • Deriy L, Chen ZC, Gao GP and Galili U: Expression of alpha-gal epitopes on HeLa cells transduced with adenovirus containing alpha1,3galactosyltransferase cDNA. Glycobiology 12: 135-144, 2002.
    • (2002) Glycobiology , vol.12 , pp. 135-144
    • Deriy, L.1    Chen, Z.C.2    Gao, G.P.3    Galili, U.4
  • 67
    • 84855573766 scopus 로고    scopus 로고
    • Conversion of tumors into autologous vaccines by intratumoral injection of α-Gal glycolipids that induce anti-Gal/α-Gal epitope interaction
    • Galili U: Conversion of tumors into autologous vaccines by intratumoral injection of α-Gal glycolipids that induce anti-Gal/α-Gal epitope interaction. Clin Dev Immunol 2011: 134020, 2011.
    • (2011) Clin Dev Immunol , vol.2011 , pp. 134020
    • Galili, U.1
  • 68
    • 0028179056 scopus 로고
    • Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
    • Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D and Levitsky H: Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961-965, 1994.
    • (1994) Science , vol.264 , pp. 961-965
    • Huang, A.Y.1    Golumbek, P.2    Ahmadzadeh, M.3    Jaffee, E.4    Pardoll, D.5    Levitsky, H.6
  • 69
    • 0026017326 scopus 로고
    • Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies
    • Manca F, Fenoglio D, Li Pira G, Kunkl A and Celada F: Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med 173: 37-48, 1991.
    • (1991) J Exp Med , vol.173 , pp. 37-48
    • Manca, F.1    Fenoglio, D.2    Li Pira, G.3    Kunkl, A.4    Celada, F.5
  • 70
    • 68549140182 scopus 로고    scopus 로고
    • Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity
    • Abdel-Motal UM, Wigglesworth K and Galili U: Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity. Cancer Immunol Immunother 58: 1545-1556, 2009.
    • (2009) Cancer Immunol Immunother , vol.58 , pp. 1545-1556
    • Abdel-Motal, U.M.1    Wigglesworth, K.2    Galili, U.3
  • 71
    • 0029794846 scopus 로고    scopus 로고
    • Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccines
    • Schweighoffer T, Schmidt W, Buschle M and Birnstiel ML: Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccines. Gene Ther 3: 819-824, 1996.
    • (1996) Gene Ther , vol.3 , pp. 819-824
    • Schweighoffer, T.1    Schmidt, W.2    Buschle, M.3    Birnstiel, M.L.4
  • 72
    • 0030049224 scopus 로고    scopus 로고
    • Fc gamma RII on human B cells can mediate enhanced antigen presentation
    • Liu C1, Gosselin EJ and Guyre PM: Fc gamma RII on human B cells can mediate enhanced antigen presentation. Cell Immunol 167: 188-194, 1996.
    • (1996) Cell Immunol , vol.167 , pp. 188-194
    • Liu, C.I.1    Gosselin, E.J.2    Guyre, P.M.3
  • 73
    • 0033565256 scopus 로고    scopus 로고
    • Increased immunogenicity of tumor vaccines complexed with anti-Gal: Studies in knockout mice for alpha1,3galactosyltransferase
    • LaTemple DC, Abrams JT, Zhang SY and Galili U: Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. Cancer Res 59: 3417-3423, 1999.
    • (1999) Cancer Res , vol.59 , pp. 3417-3423
    • LaTemple, D.C.1    Abrams, J.T.2    Zhang, S.Y.3    Galili, U.4
  • 74
    • 84917711068 scopus 로고    scopus 로고
    • Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells
    • Tanida T, Tanemura M, Miyoshi E, Nagano H, Furukawa K, Nonaka Y, Akita H, Hama N, Wada H, Kawamoto K, et al: Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells. Int J Oncol 46: 78-90, 2015.
    • (2015) Int J Oncol , vol.46 , pp. 78-90
    • Tanida, T.1    Tanemura, M.2    Miyoshi, E.3    Nagano, H.4    Furukawa, K.5    Nonaka, Y.6    Akita, H.7    Hama, N.8    Wada, H.9    Kawamoto, K.10
  • 75
    • 84874458512 scopus 로고    scopus 로고
    • Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer
    • Tanemura M, Miyoshi E, Nagano H, Eguchi H, Taniyama K, Kamiike W, Mori M and Doki Y: Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer. Cancer Sci 104: 282-290, 2013.
    • (2013) Cancer Sci , vol.104 , pp. 282-290
    • Tanemura, M.1    Miyoshi, E.2    Nagano, H.3    Eguchi, H.4    Taniyama, K.5    Kamiike, W.6    Mori, M.7    Doki, Y.8
  • 76
    • 77954363486 scopus 로고    scopus 로고
    • Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: A novel approach to immunotherapy in pancreatic cancer
    • Deguchi T, Tanemura M, Miyoshi E, Nagano H, Machida T, Ohmura Y, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, et al: Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: A novel approach to immunotherapy in pancreatic cancer. Cancer Res 70: 5259-5269, 2010.
    • (2010) Cancer Res , vol.70 , pp. 5259-5269
    • Deguchi, T.1    Tanemura, M.2    Miyoshi, E.3    Nagano, H.4    Machida, T.5    Ohmura, Y.6    Kobayashi, S.7    Marubashi, S.8    Eguchi, H.9    Takeda, Y.10
  • 77
    • 84867009699 scopus 로고    scopus 로고
    • Cancer immunotherapy by intratumoral injection of α-gal glycolipids
    • Whalen GF, Sullivan M, Piperdi B, Wasseff W and Galili U: Cancer immunotherapy by intratumoral injection of α-gal glycolipids. Anticancer Res 32: 3861-3868, 2012.
    • (2012) Anticancer Res , vol.32 , pp. 3861-3868
    • Whalen, G.F.1    Sullivan, M.2    Piperdi, B.3    Wasseff, W.4    Galili, U.5
  • 78
    • 0029978369 scopus 로고    scopus 로고
    • Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody
    • Galili U, Repik PM, Anaraki F, Mozdzanowska K, Washko G and Gerhard W: Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody. Vaccine 14: 321-328, 1996.
    • (1996) Vaccine , vol.14 , pp. 321-328
    • Galili, U.1    Repik, P.M.2    Anaraki, F.3    Mozdzanowska, K.4    Washko, G.5    Gerhard, W.6
  • 79
    • 0030829012 scopus 로고    scopus 로고
    • Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody
    • Henion TR, Gerhard W, Anaraki F and Galili U: Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody. Vaccine 15: 1174-1182, 1997.
    • (1997) Vaccine , vol.15 , pp. 1174-1182
    • Henion, T.R.1    Gerhard, W.2    Anaraki, F.3    Galili, U.4
  • 80
    • 33745785047 scopus 로고    scopus 로고
    • Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes
    • Abdel-Motal U, Wang S, Lu S, Wigglesworth K and Galili U: Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes. J Virol 80: 6943-6951, 2006.
    • (2006) J Virol , vol.80 , pp. 6943-6951
    • Abdel-Motal, U.1    Wang, S.2    Lu, S.3    Wigglesworth, K.4    Galili, U.5
  • 81
    • 84856718065 scopus 로고    scopus 로고
    • Accelerated porcine wound healing with a-Gal nanoparticles
    • Hurwitz ZIR, Lalikos J and Galili U: Accelerated porcine wound healing with a-Gal nanoparticles. Plast Reconstr Surg 129: 242-251, 2012.
    • (2012) Plast Reconstr Surg , vol.129 , pp. 242-251
    • Zir, H.1    Lalikos, J.2    Galili, U.3
  • 82
    • 84878319570 scopus 로고    scopus 로고
    • Discovery of the natural anti-Gal antibody and its past and future relevance to medicine
    • Galili U: Discovery of the natural anti-Gal antibody and its past and future relevance to medicine. Xenotransplantation 20: 138-147, 2013.
    • (2013) Xenotransplantation , vol.20 , pp. 138-147
    • Galili, U.1
  • 83
    • 79954998873 scopus 로고    scopus 로고
    • Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing
    • Wigglesworth KM, Racki WJ, Mishra R, Szomolanyi-Tsuda E, Greiner DL and Galili U: Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing. J Immunol 186: 4422-4432, 2011.
    • (2011) J Immunol , vol.186 , pp. 4422-4432
    • Wigglesworth, K.M.1    Racki, W.J.2    Mishra, R.3    Szomolanyi-Tsuda, E.4    Greiner, D.L.5    Galili, U.6
  • 84
    • 76349085649 scopus 로고    scopus 로고
    • Accelerated healing of skin burns by anti-Gal/alpha-gal liposomes interaction
    • Galili U, Wigglesworth K and Abdel-Motal UM: Accelerated healing of skin burns by anti-Gal/alpha-gal liposomes interaction. Burns 36: 239-251, 2010.
    • (2010) Burns , vol.36 , pp. 239-251
    • Galili, U.1    Wigglesworth, K.2    Abdel-Motal, U.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.